Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-9-29
|
pubmed:abstractText |
Thirty-five patients underwent a protocol of neo-adjuvant hormonal suppression previous to radical surgery in locally advanced stages, seven patients in stage B (T2) and 25 in stage C (T3). Three cases were not considered suitable for surgery since no clinical evidence of sub-staging was demonstrated. Clinical reassessment after neo-adjuvant therapy was conducted by rectal examination, PSA and transrectal ultrasound. Pre-hormonal average of PSA was 38.20 ng/ml (range: 1-235). Post-hormonal average was 1.15 ng/ml (range < 0.5-6.2). Clinical reduction of prostate volume was seen in 75% of patients. In three of them (9.37%) no tumour (Po) was seen in the pieces of prostatectomy.
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0210-4806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
404-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8073926-Aged,
pubmed-meshheading:8073926-Androgen Antagonists,
pubmed-meshheading:8073926-Chemotherapy, Adjuvant,
pubmed-meshheading:8073926-Combined Modality Therapy,
pubmed-meshheading:8073926-Humans,
pubmed-meshheading:8073926-Male,
pubmed-meshheading:8073926-Middle Aged,
pubmed-meshheading:8073926-Neoplasm Staging,
pubmed-meshheading:8073926-Prostatectomy,
pubmed-meshheading:8073926-Prostatic Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
[Clinical impact of neoadjuvant treatment to radical prostatectomy in locally advanced prostatic cancer].
|
pubmed:affiliation |
Fundación Puigvert, Barcelona.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|